Clinical trials sponsored by University Hospital, Grenoble

Phase breakdown

Conditions studied

Recruiting trials led by University Hospital, Grenoble

• Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)
  NCT05193591 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Atlas of Human Cognition by SEEG (MAPCOG-SEEG)
  NCT03644732 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 4 locations
• Cardiovascular Risk and Chronic Obstructive Pulmonary Disease
  NCT03014609 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Efficacy of Morphine in Reducing the Rate of Early Non-Invasive Ventilation Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Phase I/IIa
  NCT04427826 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Enabling Women with Parkinson's Disease to Identify and Better Manage Hormonal Triggers of Parkinsonian Symptoms
  NCT06582212 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 56 Years · Sex: Female · 4 locations
• Endoscopic Sutured Gastroplasty with Endomina® Device Versus Standard of Care in Patients with Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial
  NCT05516576 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
  NCT02844049 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 69 Years · Sex: All (male and female) · 8 locations
• Evaluation of Deep Brain Stimulation (DBS) of the Right Operculum 3 (OP3) in Permanent Non-pulsatile Disabling Tinnitus (TINNOP3-DBS)
  NCT04296097 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment
  NCT06611007 · Phase: Phase 1, Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Impact of Mindfulness Intervention on Quality of Life in Patients With Drug-resistant Epilepsy.
  NCT04126369 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
  NCT05704881 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Preparation and Feasibility of Exams for Expected Studies
  NCT05698810 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
  NCT06154668 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer
  NCT06828263 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• Real Life Data From Hypertensive Patients Treated With Renal Denervation in Current Practice in France- French RENal Denervation Registry
  NCT07206030 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease
  NCT05385315 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Training of Nursing Home Professionals and Quality of Life of Residents With Parkinson's Disease
  NCT06908460 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms
  NCT05038358 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins
  NCT06481878 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is University Hospital, Grenoble recruiting for?

University Hospital, Grenoble is the lead sponsor of 19 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.